Biotech | April 20, 2022
MicroGEM granted EUA for Covid-19 PCR Saliva test
The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes
The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes
Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer
Ind-Ra expects FY22 IPM to have witnessed 15% YoY sales growth, higher than the 8%-10% observed over the past five years, aided by the base effect
Ind-Ra maintains a neutral outlook for healthcare in FY23
The brand Azmarda fits well with JBCPL's overall strategy of strengthening its presence in the cardiology segment in India.
The plant is scheduled to come on stream in September 2024
India accounts for more than half (almost 60%) of new leprosy cases worldwide, despite being declared ‘leprosy-free’ in 2005.
Tardive dyskinesia (TD) is a movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients
Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project
Launched in the year 2018, MedEngage Scholarship Program is aimed at nurturing and nourishing medical talent in India
Subscribe To Our Newsletter & Stay Updated
